Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Taxotere Lawsuit Parties Select Four Bellwether Trial Candidates

Federal lawsuits filed on behalf of cancer patients who allegedly experienced permanent hair loss related to treatment with Taxotere are moving forward in the U.S. District Court, Eastern District of Louisiana. According to a Case Management Order issued by the … Continue reading

FDA Adverse Event Reports Indicate 28 Remicade Patients Diagnosed with TTP During First Two Years of Treatment

A recent analysis of adverse event reports made to the U.S. Food & Drug Administration (FDA) indicates that at least 28 Remicade patients had developed (Thrombotic Thrombocytopenic Purpura) as of March 9, 2018. In all cases, the dangerous and potentially … Continue reading

Proton Pump Inhibitor Side Effect Concerns Mount, as New Study Points to Possible Link with Depression

New research is pointing to more proton pump inhibitor complications, this time a possible link to major depressive disorder. The findings come as concerns continue to mount over the side effects potentially associated with the use of these popular heart … Continue reading

Federal Court Overseeing C.R. Bard IVC Filter Lawsuits Clears Way for Second Bellwether Trial

The federal court overseeing thousands of IVC filter lawsuits filed against C.R. Bard, Inc. has cleared the way for the litigation’s second bellwether trial, after denying the company’s bid to dismiss the plaintiffs’ failure-to-warn and punitive damage claims. Plaintiff Alleges … Continue reading

Risperdal Lawsuit News: Pennsylvania Supreme Court Weighing Whether to Hear Statute of Limitations Appeal

Risperdal gynecomastia plaintiffs could soon learn if the Pennsylvania Supreme Court will hear an appeal of a lower court decision that, if confirmed, will prevent hundreds from pursuing their claims. When Does the Statute of Limitations Expire for Risperdal Lawsuits? … Continue reading

Federal Court Overseeing Ethicon Hernia Mesh Lawsuits Issues 8th Practice and Procedure Order

Hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh Flexible Composite mesh products continue to move forward in the U.S. District Court, Northern District of Georgia, where all such federal claims are undergoing coordinated pretrial proceedings before a single judge. The Court … Continue reading

Talcum Powder Lawsuits Mount Against Johnson & Johnson, as SEC Filing Discloses 6,600 Pending Claims

Johnson & Johnson continues to face a growing number of legal claims filed on behalf of women who developed ovarian cancer allegedly related to their use of Baby Powder and Show-to-Shower talc-based powders for feminine hygiene purposes. According to the … Continue reading

Indiana Woman Awarded $35 Million for Defective Prolift Mesh, as Johnson & Johnson Loses Another Transvaginal Mesh Lawsuit

An Indiana woman has been awarded $35 million, after the federal jury hearing her transvaginal mesh lawsuit found that Johnson & Johnson and its Ethicon, Inc. subsidiary committed negligence in designing and marketing Prolift mesh implants for the treatment of … Continue reading

Biogen, AbbVie Announce Global Zinbryta Recall in Response to Reports Linking MS Drug to Fatal Encephalitis

Biogen Inc. and AbbVie Inc. have taken the rare step of issuing a worldwide drug recall for Zinbryta, after the multiple sclerosis (MS) drug was tied to reports of encephalitis and other inflammatory brain disorders, some of which were fatal. What … Continue reading

Another Study Suggests Aortic Risks from Levaquin, Other Fluoroquinolone Antibiotics

Yet another study has suggested that patients who take Levaquin or fluoroquinolone antibiotics face an increased risk for life-threatening aortic disorders, including aortic aneurysm and aortic dissection. The research, which was published this month in the British Medical Journal, drew … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content